By Katherine Hamilton
Shares of Cargo Therapeutics rose after the company said it plans to cease development for more treatments and review strategic options.
The stock rose 17% to $4.44 on Tuesday after the market closed. Shares have fallen 74% over the past three months.
The biotechnology company, which focuses on curative cell therapies for cancer patients, said Tuesday it is reducing its workforce by 90% and discontinuing development of its remaining pipeline assets. Its chief executive is also departing.
Cargo is reviewing strategic options and working with TD Cowen as a financial adviser, it said.
Board Chairman John Owin said Cargo wants to find a permanent home for its remaining assets and maximize value for shareholders.
The announcement comes about two months after Cargo said it would discontinue a study of firi-cel and cut its workforce in half. Shares fell to $3.39 from $13.19 after that announcement.
Write to Katherine Hamilton at katherine.hamilton@wsj.com
(END) Dow Jones Newswires
March 18, 2025 17:19 ET (21:19 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。